211 related articles for article (PubMed ID: 32740174)
41. Expression Profile of Circulating Exosomal microRNAs in Leukoplakia, Oral Submucous Fibrosis, and Combined Lesions of Leukoplakia and Oral Submucous Fibrosis.
Yasothkumar D; Ramani P; Jayaraman S; Ramalingam K; Tilakaratne WM
Head Neck Pathol; 2024 Mar; 18(1):28. PubMed ID: 38536520
[TBL] [Abstract][Full Text] [Related]
42. Oral submucous fibrosis, a clinically benign but potentially malignant disease: report of 3 cases and review of the literature.
Auluck A; Rosin MP; Zhang L; Sumanth KN
J Can Dent Assoc; 2008 Oct; 74(8):735-40. PubMed ID: 18845065
[TBL] [Abstract][Full Text] [Related]
43. Analysis Of Serum Iron And Heamoglobin Level In Patients With Oral Submucous Fibrosis.
Urooj A; Ali A; Agha A; Ahmed Syed SI; Zaheer M
J Ayub Med Coll Abbottabad; 2022; 34(1):173-177. PubMed ID: 35466648
[TBL] [Abstract][Full Text] [Related]
44. Oral Submucous Fibrosis: Etiological Mechanism, Malignant Transformation, Therapeutic Approaches and Targets.
Qin X; Ning Y; Zhou L; Zhu Y
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902423
[TBL] [Abstract][Full Text] [Related]
45. Myofibroblasts in oral potentially malignant disorders: Is it related to malignant transformation?
Coletta RD; Salo T
Oral Dis; 2018 Mar; 24(1-2):84-88. PubMed ID: 29480603
[TBL] [Abstract][Full Text] [Related]
46. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
Sudha VM; Hemavathy S
Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
[TBL] [Abstract][Full Text] [Related]
47. p53 aberrations in oral sub mucous fibrosis and oral cancer detected by immunohistochemistry.
Bathi RJ; Prabhat
Indian J Dent Res; 2003; 14(4):214-9. PubMed ID: 15328987
[TBL] [Abstract][Full Text] [Related]
48. Oral submucous fibrosis: Comparing clinical grading with duration and frequency of habit among areca nut and its products chewers.
Ali FM; Aher V; Prasant MC; Bhushan P; Mudhol A; Suryavanshi H
J Cancer Res Ther; 2013; 9(3):471-6. PubMed ID: 24125985
[TBL] [Abstract][Full Text] [Related]
49. Immunolocalization of c-Jun in normal mucosa, oral submucous fibrosis, epithelial dysplasia, and oral squamous cell carcinoma: A comparative study.
Shraddha KS; Niranjan KC; Hallikeri K
J Cancer Res Ther; 2018; 14(6):1180-1183. PubMed ID: 30488826
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of stromal myofibroblasts in oral leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma--an immunohistochemical study.
Gupta K; Metgud R; Gupta J
J Cancer Res Ther; 2015; 11(4):893-8. PubMed ID: 26881537
[TBL] [Abstract][Full Text] [Related]
51. Epidemiological survey of oral submucous fibrosis in Xiangtan City, Hunan Province, China.
Tang JG; Jian XF; Gao ML; Ling TY; Zhang KH
Community Dent Oral Epidemiol; 1997 Apr; 25(2):177-80. PubMed ID: 9181294
[TBL] [Abstract][Full Text] [Related]
52. Clinically malignant exophytic lesions in the background of oral submucous fibrosis: report of five cases.
Jayasinghe LA; Peiris PM; Tilakaratne WM; Attygalla AM; Jayasinghe RD; Sitheeque MA; Siriwardena BS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):210-5. PubMed ID: 27422419
[TBL] [Abstract][Full Text] [Related]
53. CD1a+ and CD207+ cells are reduced in oral submucous fibrosis and oral squamous cell carcinoma.
Silva LC; Fonseca FP; Almeida OP; Mariz BA; Lopes MA; Radhakrishnan R; Sharma M; Kowalski LP; Vargas PA
Med Oral Patol Oral Cir Bucal; 2020 Jan; 25(1):e49-e55. PubMed ID: 31880289
[TBL] [Abstract][Full Text] [Related]
54. Potentiated action on the progression of OSMF by hypoxia mediated signaling pathway by the epithelial mesenchymal transition and angiogenic apparatus.
Gupta S; Shetty DC; Gulati N; Juneja S; Jain A
J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147960
[TBL] [Abstract][Full Text] [Related]
55. Oral submucous fibrosis. A review.
Cox SC; Walker DM
Aust Dent J; 1996 Oct; 41(5):294-9. PubMed ID: 8961601
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of myofibroblasts in oral submucous fibrosis and oral squamous cell carcinoma: The pathogenesis and correlation.
Gandhi P; Prasad UC
Dent Res J (Isfahan); 2017; 14(5):314-320. PubMed ID: 29109745
[TBL] [Abstract][Full Text] [Related]
57. Significance of HIF-1α and CD105 in establishing oral squamous cell carcinoma associated with oral submucous fibrosis a distinct clinicopathological entity.
Hande AH; Chaudhary MS; Gadbail AR; Gawande MN; Patil SK; Zade PR; Sharma PN; Jaiswal SG; Sonone AM
J Cancer Res Ther; 2022; 18(1):33-41. PubMed ID: 35381759
[TBL] [Abstract][Full Text] [Related]
58. Qualitative Assessment of Collagen and Elastic Fibers in Oral Submucous Fibrosis (OSMF), OSMF with Dysplasia and Oral Squamous Cell Carcinoma Arising from OSMF: A Histochemical Study.
Pandiar D; Aswani E; Krishnan RP
Head Neck Pathol; 2023 Dec; 17(4):932-939. PubMed ID: 37843734
[TBL] [Abstract][Full Text] [Related]
59. [Oral squamous cell carcinoma in the background of oral submucous fibrosis - a systematic review].
Kizhakkoottu S; Ramani P
Arkh Patol; 2024; 86(1):57-64. PubMed ID: 38319274
[TBL] [Abstract][Full Text] [Related]
60. Effect of betel chewing, tobacco smoking and alcohol consumption on oral submucous fibrosis: a case-control study in Sri Lanka.
Ariyawardana A; Athukorala AD; Arulanandam A
J Oral Pathol Med; 2006 Apr; 35(4):197-201. PubMed ID: 16519765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
